Search results for "ISM [Radio continuum]"

showing 10 items of 703 documents

Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study

2017

AbstractPatients with intermediate-risk pulmonary embolism (PE) may, depending on the method and cut-off values used for definition, account for up to 60% of all patients with PE and have an 8% or higher risk of short-term adverse outcome. Although four non-vitamin K-dependent direct oral anticoagulants (NOACs) have been approved for the treatment of venous thromboembolism, their safety and efficacy as well as the optimal anticoagulation regimen using these drugs have not been systematically investigated in intermediate-risk PE. Moreover, it remains unknown how many patients with intermediate-high-risk and intermediate-low-risk PE were included in most of the phase III NOAC trials. The ongo…

MaleRiskmedicine.medical_specialtypulmonary embolismDrug-Related Side Effects and Adverse Reactionsmedicine.medical_treatmentHemorrhageintermediate risk030204 cardiovascular system & hematologyDabigatran03 medical and health sciencesYoung Adult0302 clinical medicineRecurrenceInternal medicineGermanymedicineHumansdabigatran030212 general & internal medicineProspective StudiesProspective cohort studySurvival analysisvenous thromboembolism recurrencebusiness.industryHeparinAnticoagulantsHematologyThrombolysisHeparinReference Standardsmedicine.diseaseThrombosisSurvival Analysis3. Good healthPulmonary embolismright ventricular functionRegimenTreatment OutcomeResearch Designmajor bleedingAcute Diseasedabigatran; intermediate risk; major bleeding; pulmonary embolism; right ventricular function; venous thromboembolism recurrenceFemalebusinessmedicine.drugFollow-Up Studies
researchProduct

Discovery and SAR Evolution of Pyrazole Azabicyclo[3.2.1]octane Sulfonamides as a Novel Class of Non-Covalent N-Acylethanolamine-Hydrolyzing Acid Ami…

2021

Inhibition of intracellular N-acylethanolamine-hydrolyzing acid amidase (NAAA) activity is a promising approach to manage the inflammatory response under disabling conditions. In fact, NAAA inhibition preserves endogenous palmitoylethanolamide (PEA) from degradation, thus increasing and prolonging its anti-inflammatory and analgesic efficacy at the inflamed site. In the present work, we report the identification of a potent, systemically available, novel class of NAAA inhibitors, featuring a pyrazole azabicyclo[3.2.1]octane structural core. After an initial screening campaign, a careful structure–activity relationship study led to the discovery of endo-ethoxymethyl-pyrazinyloxy-8-azabicyclo…

MaleStereochemistryAnti-Inflammatory AgentsPeptides and proteinsPyrazoleArticleAmidohydrolasesAmidaseRats Sprague-DawleyStructure-Activity Relationshipchemistry.chemical_compoundIn vivoN-AcylethanolamineDrug DiscoverymedicineAnimalsHumansSulfonesEnzyme InhibitorsIC50InhibitionInflammationchemistry.chemical_classificationPalmitoylethanolamideMolecular StructureInhibitorsSulfonamideMice Inbred C57BLMolecular Docking SimulationMechanism of actionchemistryMicrosomes LiverInhibitorsInhibitionSulfonesPeptides and proteinsInflammationPyrazolesMolecular Medicinemedicine.symptomProtein BindingTropanesJournal of Medicinal Chemistry
researchProduct

Early Seizures After Acute Stroke: A Study of 1,640 Cases

1994

We evaluated prospectively the occurrence of seizures within 15 days of a first stroke or transient ischemic episode in 1,640 patients to study relation between seizures and type of stroke. Seizures occurred in 90 patients (5.4%), including 36 (4.4%) of 814 with infarct owing to atheroma, 21 (16.6%) of 126 with infarct owing to cardiogenic embolus, 3 (1%) of 273 owing to lacunar infarct, 5 (1.9%) of 259 owing to transient ischemic attack (TIA), 21 (16.2%) of 129 owing to supratentorial hematoma, and 4 (16.6%) of 24 owing to subarachnoid hemorrhage. Thirteen (14.6%) of 89 subcortical infarcts were associated with seizures. Seizures were the initial sign of stroke in 80 (89%) of 90 cases and …

MaleSubarachnoid hemorrhageComorbidityCentral nervous system diseaseHematomaEmbolusmedicineHumansProspective StudiesRegistriescardiovascular diseasesProspective cohort studyStrokeAgedAged 80 and overEpilepsybusiness.industryVascular diseaseIncidenceCerebral InfarctionIntracranial Embolism and ThrombosisMiddle AgedSubarachnoid HemorrhageIntracranial Arteriosclerosismedicine.diseaseCerebrovascular DisordersNeurologyEmbolismIschemic Attack TransientAnesthesiacardiovascular systemRegression AnalysisFemaleFranceNeurology (clinical)businessEpilepsia
researchProduct

Antiasthmatic effects of onions: Inhibition of 5-lipoxygenase and cyclooxygenase in vitro by thiosulfinates and “Cepaenes”

1990

Nine thiosulfinates (TS) and four "Cepaenes" (CS) isolated from onions and/or synthetized by us showed dose dependent (0.25 to 100 microM) marked inhibitory effects on both cyclooxygenase (CA, tested on sheep seminal vesicle microsomes) and 5-lipoxygenase activity (LO, tested on porcine leukocytes). The following rank order of activity was observed: saturated aliphatic TS less than aromatic TS approximately alpha, beta-unsaturated TS less than CS. CS inhibited both CA and LO by more than 75% at 10 and 1 microM concentrations respectively. Most likely, these in vitro effects are responsible for antiinflammatory and antiasthmatic properties of onion extracts observed in vivo, at least in part.

MaleSwineClinical BiochemistryArachidonic AcidsPharmacologyAlliumStructure-Activity RelationshipLipoxygenasemedicineAnimalsCyclooxygenase InhibitorsDisulfidesLipoxygenase InhibitorsThiosulfinateArachidonic AcidSheepbiologyPlant ExtractsChemistryCell BiologySulfinic AcidsAsthmaIn vitroBiochemistryMechanism of actionEnzyme inhibitorArachidonate 5-lipoxygenasebiology.proteinMicrosomeCyclooxygenasemedicine.symptomProstaglandins, Leukotrienes and Essential Fatty Acids
researchProduct

Red Cell Filterability and Erythrocyte Membrane Microviscosity during Ticlopidine Treatment

1990

The effects of 10 days' treatment with 500 mg/day ticlopidine on the filterability of red blood cells in suspension and on the microviscosity of the red blood cell membrane was evaluated in 11 patients with vascular atherosclerosis. The results show ticlopidine to be effective in influencing the rheological measures of red cell filterability and membrane microviscosity: filterability was increased and microviscosity was decreased. Ticlopidine also decreased the extent of fluorescence polarization. These results are discussed regarding possible mechanisms of action of ticlopidine.

MaleTiclopidineArteriosclerosis030204 cardiovascular system & hematologyPharmacologyBiochemistryMicroviscosity03 medical and health sciences0302 clinical medicineErythrocyte DeformabilitymedicineHumansErythrocyte deformabilityTiclopidineRed CellViscositybusiness.industryErythrocyte MembraneBiochemistry (medical)Cell BiologyGeneral MedicineArteriosclerosismedicine.diseaseRed blood cellErythrocyte membranemedicine.anatomical_structureMechanism of actionBiochemistry030220 oncology & carcinogenesisFemalemedicine.symptomRheologybusinessmedicine.drugJournal of International Medical Research
researchProduct

Ascorbic acid antagonizes ethanol-induced locomotor activity in the open-field.

1999

Abstract It has been reported that ascorbic acid (AA) antagonizes the physiological and behavioral effects of dopamine (DA). AA reduces locomotor activity induced by dopaminergic agonist drugs. Also, AA amplifies the action of antidopaminergic drugs. Ethanol, like other drugs, produces a release of DA in the mesolimbic pathway, and at some doses, induces locomotor activity in mice. The ethanol-induced locomotor activity could be dopamine-dependent because it can be reduced by antidopaminergic drugs. In the present study, we investigated whether an acute administration of AA reduces ethanol-induced locomotor behavior. AA, at doses (0.0, 21.85, 87.5, 175, 350, and 1400 mg/kg) was injected IP …

MaleTime FactorsClinical BiochemistryMesolimbic pathwayAscorbic AcidPharmacologyMotor ActivityToxicologyBiochemistryOpen fieldAntioxidantsBehavioral Neurosciencechemistry.chemical_compoundMiceDopaminemedicineAnimalsAmphetamineBiological PsychiatryPharmacologyAnalysis of VarianceEthanolDose-Response Relationship DrugEthanolIllicit DrugsDopaminergicAscorbic acidMechanism of actionchemistrymedicine.symptomDrug Antagonismmedicine.drugPharmacology, biochemistry, and behavior
researchProduct

Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study

2022

There is increasing evidence that early liver transplantation (eLT), performed within standardized protocols can improve survival in severe alcoholic hepatitis (sAH). The aim of the study was to assess outcomes after eLT for sAH in four Italian LT centers and to compare them with non-responders to medical therapy excluded from eLT. Patients admitted for sAH (2013–2019), according to NIAAA criteria, were included. Patients not responding to medical therapy were placed on the waiting list for eLT after a strict selection. Histological features of explanted livers were evaluated. Posttransplant survival and alcohol relapse were evaluated. Ninety-three patients with severe AH were evaluated (65…

Maleclinical decision-makingTransplantationWaiting Listsalcoholism and substance abuseHepatitis AlcoholicPatient SelectionalllocationSettore MED/09 - MEDICINA INTERNAalcoholism and substance abuse; clinical decision-making; clinical research/practice; liver transplantation/hepatologyalcoholic hepatitiMiddle Agedclinical research/practiceLiver TransplantationRecurrenceMED/18 - CHIRURGIA GENERALEHumansImmunology and AllergyFemaleethicPharmacology (medical)Liver transplantliver transplantation/hepatologyAmerican Journal of Transplantation
researchProduct

Ethanol Modulates Corticotropin Releasing Hormone Release From the Rat Hypothalamus: Does Acetaldehyde Play a Role?

2010

BACKGROUND AND METHODS Ethanol (EtOH) activates hypothalamic-pituitary-adrenal (HPA) axis, resulting in adrenocorticotropin hormone, glucocorticoid release, and in modifications of the response of the axis to other stressors. The initial site of EtOH action within the HPA system seems to be the hypothalamus. Thus, to determine the mechanisms responsible for these effects, we investigated: (i) whether EtOH was able to release corticotrophic releasing hormone (CRH) from incubated hypothalamic explants; (ii) whether acetaldehyde (ACD), its first metabolite formed in the brain by catalase activity, might play a role in EtOH activity. To this aim, rat hypothalamic explants were incubated with: (…

Maleendocrine systemmedicine.medical_specialtySettore BIO/14 - FARMACOLOGIACorticotropin-Releasing HormoneHypothalamusMedicine (miscellaneous)AcetaldehydeIn Vitro TechniquesToxicologychemistry.chemical_compoundCorticotropin-releasing hormoneInternal medicinemental disordersmedicineAnimalsRats Wistarreproductive and urinary physiologyEthanolbiologyEthanolAcetaldehydeRatsPsychiatry and Mental healthEndocrinologyMechanism of actionchemistryEthanol Acetaldehyde Hypothalamic CRH Release 3-Amino-124-triazole d-Penicillamine.CatalaseHypothalamusCRHbiology.proteinLiberationmedicine.symptomhormones hormone substitutes and hormone antagonistsGlucocorticoidmedicine.drug
researchProduct

Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease …

2020

ObjectivesThis study provides an overview of the influence of occupational risk factors on the global burden of disease as estimated by the occupational component of the Global Burden of Disease (GBD) 2016 study.MethodsThe GBD 2016 study estimated the burden in terms of deaths and disability-adjusted life years (DALYs) arising from the effects of occupational risk factors (carcinogens; asthmagens; particulate matter, gases and fumes (PMGF); secondhand smoke (SHS); noise; ergonomic risk factors for low back pain; risk factors for injury). A population attributable fraction (PAF) approach was used for most risk factors.ResultsIn 2016, globally, an estimated 1.53 (95% uncertainty interval 1.39…

Maleexposure assessmentGlobal Healthmedicine.disease_causeGlobal Burden of DiseaseergonomicGBD 2016 Occupational Risk Factors Collaborators0302 clinical medicineRisk Factors1599 Other Commerce Management Tourism and ServicesNeoplasmsMETABOLIC RISKSPer capitaMedicine1506030212 general & internal medicinePublic Environmental & Occupational HealthAged 80 and overeducation.field_of_studyHuman factors and ergonomicsMiddle Aged030210 environmental & occupational health3142 Public health care science environmental and occupational health3. Good healthOccupational DiseasesCOMPARATIVE RISK-ASSESSMENTFemaleQuality-Adjusted Life YearsRisk assessmentLife Sciences & BiomedicineAdultCOUNTRIESnoiseAdolescentPopulationcancer; ergonomic; noise; respiratory tract diseases; workplaceRisk AssessmentEnvironmental & Occupational HealthAsbestosrespiratory tract disease1117 Public Health and Health ServicesYoung Adult03 medical and health sciencesAge DistributionLife ExpectancyOccupational ExposureEnvironmental healthHumanscancerDisabled PersonsSex DistributioneducationAgedScience & Technologybusiness.industryPublic Health Environmental and Occupational Health1103 Clinical SciencesTRENDSQuality-adjusted life yearrespiratory tract diseasesworkplaceSocioeconomic FactorsAttributable riskCommentaryLife expectancyWounds and InjuriesCLUSTERSbusinessLow Back PainOccupational and Environmental Medicine
researchProduct

Left atrial thrombi despite anticoagulant and antiplatelet therapy

1994

To investigate risk factors for embolization in patients with echocardiographically detected left atrial thrombi and to evaluate thrombus development, we examined 29 patients with transesophageal and transthoracic echocardiography at two points during a follow-up of 18 months. We compared patients with a history of possible arterial embolization (n = 13) with those without (n = 16) in regard to age, gender, left atrial dilatation, localization of the thrombus in the left atrial cavity, spontaneous echo contrast, and atrial fibrillation. Eight patients were treated with aspirin, 20 with phenprocoumon. Only left atrial spontaneous contrast was associated with thromboembolism (10/15 patients w…

Malemedicine.medical_specialtyArterial embolismHeart Diseasesmedicine.drug_classmedicine.medical_treatmentEmbolismRisk FactorsInternal medicineAtrial FibrillationmedicineHumansMitral Valve StenosisHeart Atriacardiovascular diseasesEmbolizationThrombusAgedPeripheral Vascular DiseasesAspirinHeparinbusiness.industryArterial EmbolizationAnticoagulantThrombosisAtrial fibrillationGeneral MedicineIntracranial Embolism and ThrombosisMiddle Agedmedicine.diseaseThrombosisSurgeryEmbolismEchocardiographyPhenprocoumoncardiovascular systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealDilatation PathologicFollow-Up Studiescirculatory and respiratory physiologyClinical Cardiology
researchProduct